Cultural Perspectives on the Efficacy and Adoption of the Crohn's Disease Exclusion Diet across Diverse Ethnicities: A Case-Based Overview
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The Crohn's Disease Exclusion Diet (CDED) effectively induces remission in mild-to-moderate Crohn's disease across cultures. Healthcare providers successfully adapted CDED using tailored guidance and recipes for diverse patient needs.
Area Of Science
- Gastroenterology
- Clinical Nutrition
- Dietary Therapy
Background
- The Crohn's Disease Exclusion Diet (CDED) is a whole-foods diet proven effective for inducing remission in pediatric and adult Crohn's disease.
- CDED is now recognized in ESPEN guidelines, with growing international adoption beyond its initial studies in Israel.
- Cultural adaptations are crucial for successful implementation of dietary therapies like CDED.
Purpose Of The Study
- To document collective experiences with the Crohn's Disease Exclusion Diet (CDED) across diverse cultural settings.
- To identify challenges encountered during CDED implementation in various regions.
- To present solutions and strategies for overcoming cultural barriers in dietary therapy for Crohn's disease.
Main Methods
- A case-based study involving healthcare providers (dietitians and physicians) from six countries and eight cultural settings.
- Gathering collective experiences on the utilization of the Crohn's Disease Exclusion Diet (CDED).
- Analyzing challenges and devising solutions for cultural adaptation of the CDED.
Main Results
- The Crohn's Disease Exclusion Diet (CDED) demonstrates efficacy across diverse cultural contexts.
- Healthcare providers successfully tailored the CDED to accommodate patients' cultural behaviors and traditions.
- Strategies for overcoming implementation challenges include customized diets and personalized counseling.
Conclusions
- The Crohn's Disease Exclusion Diet (CDED) is a viable and effective dietary therapy for Crohn's disease in various cultural settings.
- Dietitians play a critical role in adapting CDED to individual patient needs, cultural practices, and traditions.
- Adjusted recipes and personalized guidance are key to successful international adoption of the CDED.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...